BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)

2005 ◽  
Vol 23 (4) ◽  
pp. 363-368 ◽  
Author(s):  
R.-D. Hofheinz ◽  
C. Porta ◽  
G. Hartung ◽  
A. Santoro ◽  
A.-R. Hanauske ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Anticancer Drug ◽  
Phase Ii ◽  
European Society ◽  
Drug Research ◽  
Phase Ii Study ◽  
Study Group ◽  
Central European ◽  
Group Trial

scholarly journals Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

2018 ◽  
Vol 21 (5) ◽  
pp. 802-810 ◽  
Author(s):  
Hyeong Su Kim ◽  
Min-Hee Ryu ◽  
Dae Young Zang ◽  
Sook Ryun Park ◽  
Boram Han ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Study Group ◽  
Cancer Study ◽  
Cancer Study Group

Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study

2007 ◽  
Vol 62 (2) ◽  
pp. 263-270 ◽  
Author(s):  
Yeul Hong Kim ◽  
Hyun Cheol Chung ◽  
Won Ki Kang ◽  
Sook Ryun Park ◽  
Chul Soo Kim ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Study Group ◽  
Cancer Study ◽  
Multicenter Phase ◽  
Cancer Study Group
Sign in / Sign up

Export Citation Format

Share Document